Next |
home / stock / dare / dare message board
Subject | By | Source | When |
---|---|---|---|
whytestocks: $DARE News Article - Dar Bioscience to Participate in Xpectives.Health SUMMIT Innovatio | whytestocks | investorshangout | 04/17/2023 12:45:50 PM |
whytestocks: $DARE News Article - Dar Bioscience Reports Full Year 2022 Financial Results and Provid | whytestocks | investorshangout | 03/30/2023 4:50:50 PM |
whytestocks: $DARE News Article - Dar Bioscience to Present at the 35th Annual Roth Conference | whytestocks | investorshangout | 03/01/2023 6:25:47 PM |
Might be a runner in due time | harry crumb | investorshub | 02/02/2023 11:12:12 AM |
The $DARE train has not even left the | nonsequetor | investorshub | 01/26/2023 10:11:07 PM |
1.00 average, 100k | harry crumb | investorshub | 01/25/2023 6:38:44 PM |
I hope everyone loaded up Monday... | nonsequetor | investorshub | 01/25/2023 3:59:17 PM |
Monday, Jan 23, is the day... | nonsequetor | investorshub | 01/21/2023 4:47:11 PM |
Yep agree | harry crumb | investorshub | 01/11/2023 6:50:52 PM |
If Ovaprene is approved by the FDA, it | nonsequetor | investorshub | 01/11/2023 5:23:04 PM |
DARE starts revenue soon with its first approved | nonsequetor | investorshub | 01/11/2023 5:20:23 PM |
$DARE Since Post: | nonsequetor | investorshub | 01/11/2023 4:52:50 PM |
Mayb, mayb not | harry crumb | investorshub | 01/11/2023 12:58:48 PM |
Since my call | nonsequetor | investorshub | 01/11/2023 12:01:24 AM |
Could be but highly unlikely this becomes a winner | harry crumb | investorshub | 01/10/2023 5:43:44 PM |
Just a little bit of DD will prove | nonsequetor | investorshub | 01/10/2023 4:38:34 PM |
Dont count on it, this team is not | harry crumb | investorshub | 01/10/2023 1:52:22 PM |
Hop aboard, this is just the beginning! | nonsequetor | investorshub | 01/09/2023 11:47:56 PM |
$DARE up over 30% already this year. | nonsequetor | investorshub | 01/09/2023 5:24:25 PM |
whytestocks: $DARE News Article - Dar Bioscience Announces Positive Pharmacokinetic (PK) Results fro | whytestocks | investorshangout | 01/09/2023 1:55:48 PM |
News, Short Squeeze, Breakout and More Instantly...
Dare Bioscience Inc. Company Name:
DARE Stock Symbol:
NASDAQ Market:
Published data shows that Ovaprene was safe and effective in a postcoital test study of 33 women Pivotal Phase 3 contraceptive efficacy clinical study of Ovaprene currently enrolling Ovaprene has the potential to be the first FDA-approved hormone-free monthly intravaginal contrace...
2023 Highlights and Anticipated 2024 Milestones XACIATO™ (clindamycin phosphate) vaginal gel 2% is available by prescription in the United States to treat bacterial vaginosis under license agreement with commercial collaborator Organon Ovaprene® hormone-free mont...
Swire Pacific Ltd. ADR (Class A) (SWRAY) is expected to report for Q4 2023 Troika Media Group Inc. (TRKAQ) is expected to report for quarter end 2023-12-31 American Environmental Partners Inc. (AEPT) is expected to report for quarter end 2023-12-31 Veolia Environnement S.A. ADR (VEOEY...